about
Cytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohortAnalysis of IL-6, STAT3 and HSPA1L gene polymorphisms in anti-tuberculosis drug-induced hepatitis in a nested case-control studyFine mapping of genetic polymorphisms of pulmonary tuberculosis within chromosome 18q11.2 in the Chinese population: a case-control study.Current use of oral contraceptives and the risk of first-ever ischemic stroke: A meta-analysis of observational studies.Role of polymorphic bile salt export pump (BSEP, ABCB11) transporters in anti-tuberculosis drug-induced liver injury in a Chinese cohort.Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations.Effects and safety of lanthanum carbonate in end stage renal disease patients with hyperphosphatemia: a meta-analysis--system review of lanthanum carbonate.Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity.Prevalence of primary cardiac tumor malignancies in retrospective studies over six decades: a systematic review and meta-analysis.Genetic polymorphisms of IFNG and IFNGR1 in association with the risk of pulmonary tuberculosis.Detection of occult tumor cells in regional lymph nodes is associated with poor survival in pN0 non-small cell lung cancer: a meta-analysis.CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.The association between HLA-DQB1 polymorphism and antituberculosis drug-induced liver injury: a Case-Control Study.Preventive use of hepatoprotectors yields limited efficacy on the liver toxicity of anti-tuberculosis agents in a large cohort of Chinese patients.Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis.Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy.Association of polymorphisms in drug transporter genes (SLCO1B1 and SLC10A1) and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.Association between apolipoprotein E genotype and warfarin response during initial anticoagulation.Genome-wide association study of survival in early-stage non-small cell lung cancer.Clinical Significance of 4L Lymph Node Dissection in Left Lung CancerThe association between BACH1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohortHome-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational studyMachine learning for prediction of sudden cardiac death in heart failure patients with low left ventricular ejection fraction: study protocol for a retroprospective multicentre registry in China.Interleukin-4 and interleukin-10 polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese populationAssociation of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patientsRisk factors for early death in primary malignant cardiac tumors: An analysis of over 40 years and 500 patientsAssociation between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control studyImpact of maternal reproductive factors on cancer risks of offspring: A systematic review and meta-analysis of cohort studiesAssociation of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han populationAssociation of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han populationPossible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control studyRelevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han populationThe A/A Genotype of XPO1 rs4430924 Is Associated With Higher Risk of Antituberculosis Drug-Induced Hepatotoxicity in Chinese PatientsAssociation of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysisI-κB kinase-ε knockout protects against angiotensin II induced aortic valve thickening in apolipoprotein E deficient miceAssociation between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study
P50
Q28486869-7D905AEB-C645-4ED4-A713-12DA9AE5E652Q28544718-015EC2A3-66C5-446B-A3BB-9AB07680FD31Q34054030-CA6CC1AF-FB49-4DFD-807E-470A8CE67EF1Q35621034-5D7042ED-C84B-4D74-B7DC-37FFAD45B24CQ36996132-B1282FB7-9BB7-4050-8CAD-593EF4DA8851Q37149994-64FFE007-9728-4F9F-A9B6-6A1341355DA4Q38132834-4E0613D6-A9EA-43A1-B334-2081500CFA9AQ38360770-3CFA4D6F-FEC6-47F3-B652-149F4B833C5AQ38794205-9C4493C8-03FB-4163-ACA6-134F398B57F2Q39220132-57CD39F0-3E88-4024-85D8-844878C8544EQ39434623-F03F4887-1B91-421D-8501-5CC8B6A6930BQ40765051-8FBFBCAF-DE5C-4F89-8130-914E2866066DQ44075475-488DB03D-C0E2-4779-8672-22A57DA321A9Q44239925-DAF29635-C544-4D3E-A3B3-689010C447D1Q46249138-C8025EB4-16CC-4C71-BD7B-A6E720A49BDBQ47425743-652A66EA-DD64-4692-A27F-4AA1568C3425Q50606686-E7428F9A-3675-4B0E-9894-E4CB2D831BC6Q52679343-72580902-8381-46CE-9BE3-6C41F79509E5Q54328015-7BECE398-1F16-47D4-988E-15E623822C34Q57284575-935591DE-E4B6-4ABA-B91A-602C25315456Q57476007-9AF737B4-87FA-4934-8A9C-508A473941EFQ64099619-43614A0D-A3CF-4508-A8B9-6FA48D91C812Q64983813-B08EA822-C0E5-4732-83C1-AB515B17CCFBQ85764411-495070EE-FD6A-44D5-A711-E3DAA975DE6BQ87812852-B4D681DE-E24C-479C-A6CE-24C3ACF501E9Q89364580-E1DB671B-021E-4BA8-B97D-791829AA12FFQ90497180-24C7C340-EA1F-4D43-B627-147FD5D37A50Q90743428-1A839517-9C3F-4DFF-815D-E909CDDD8866Q91348785-6C423727-6209-4867-85EC-AC2D932F0B16Q91661130-A84D7C53-7101-42C4-97BB-6CA13F79F93AQ91676476-06C67FD6-7097-4934-A1EF-99AF4F96E6FFQ91842613-59A1DEC2-7E19-4308-B9B6-8E04F5BDCA11Q92002232-5791D8FE-4C52-440C-9669-55C2C414C19AQ92648674-29C58EC0-C081-4B10-8D4A-3B558F843D58Q93334720-2C67464C-BD9B-446D-8B26-194696FB14ADQ94591132-6101C6E6-5C32-4C37-9737-A5C9A5BE413D
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Shaowen Tang
@en
Shaowen Tang
@nl
type
label
Shaowen Tang
@en
Shaowen Tang
@nl
prefLabel
Shaowen Tang
@en
Shaowen Tang
@nl
P31
P496
0000-0001-5879-8594